These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19299716)

  • 1. Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.
    Richter C; Juan MH; Will J; Brandes RP; Kalinke U; Akira S; Pfeilschifter JM; Hultqvist M; Holmdahl R; Radeke HH
    J Immunol; 2009 Apr; 182(7):4183-91. PubMed ID: 19299716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resident and monocyte-derived dendritic cells become dominant IL-12 producers under different conditions and signaling pathways.
    Zhan Y; Xu Y; Seah S; Brady JL; Carrington EM; Cheers C; Croker BA; Wu L; Villadangos JA; Lew AM
    J Immunol; 2010 Aug; 185(4):2125-33. PubMed ID: 20644172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.
    Theiner G; Rössner S; Dalpke A; Bode K; Berger T; Gessner A; Lutz MB
    Mol Immunol; 2008 Jan; 45(1):244-52. PubMed ID: 17599410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
    Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
    Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS.
    Skokos D; Nussenzweig MC
    J Exp Med; 2007 Jul; 204(7):1525-31. PubMed ID: 17576775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.
    Schmitz F; Heit A; Guggemoos S; Krug A; Mages J; Schiemann M; Adler H; Drexler I; Haas T; Lang R; Wagner H
    Eur J Immunol; 2007 Feb; 37(2):315-27. PubMed ID: 17273999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury.
    Velayudham A; Hritz I; Dolganiuc A; Mandrekar P; Kurt-Jones E; Szabo G
    J Hepatol; 2006 Dec; 45(6):813-24. PubMed ID: 16935388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
    Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
    Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
    Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
    Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses.
    Schellack C; Prinz K; Egyed A; Fritz JH; Wittmann B; Ginzler M; Swatosch G; Zauner W; Kast C; Akira S; von Gabain A; Buschle M; Lingnau K
    Vaccine; 2006 Jun; 24(26):5461-72. PubMed ID: 16678312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyD88 is dispensable for resistance to Paracoccidioides brasiliensis in a murine model of blood-borne disseminated infection.
    González A; Yáñez A; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):365-74. PubMed ID: 19049649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells.
    Sepulveda FE; Maschalidi S; Colisson R; Heslop L; Ghirelli C; Sakka E; Lennon-Duménil AM; Amigorena S; Cabanie L; Manoury B
    Immunity; 2009 Nov; 31(5):737-48. PubMed ID: 19879164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands.
    Jose P; Avdiushko MG; Akira S; Kaplan AM; Cohen DA
    Exp Lung Res; 2009 Feb; 35(1):1-28. PubMed ID: 19191102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.
    Mayer ML; Phillips CM; Stadnyk AW; Halperin SA; Lee SF
    Mol Immunol; 2009 May; 46(8-9):1883-91. PubMed ID: 19278729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
    Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
    Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.